全文获取类型
收费全文 | 890篇 |
免费 | 55篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 57篇 |
妇产科学 | 15篇 |
基础医学 | 121篇 |
口腔科学 | 3篇 |
临床医学 | 32篇 |
内科学 | 201篇 |
皮肤病学 | 9篇 |
神经病学 | 22篇 |
特种医学 | 13篇 |
外科学 | 48篇 |
综合类 | 18篇 |
一般理论 | 1篇 |
预防医学 | 36篇 |
眼科学 | 17篇 |
药学 | 46篇 |
中国医学 | 2篇 |
肿瘤学 | 306篇 |
出版年
2023年 | 2篇 |
2022年 | 9篇 |
2021年 | 25篇 |
2020年 | 18篇 |
2019年 | 17篇 |
2018年 | 18篇 |
2017年 | 18篇 |
2016年 | 21篇 |
2015年 | 26篇 |
2014年 | 29篇 |
2013年 | 40篇 |
2012年 | 62篇 |
2011年 | 76篇 |
2010年 | 27篇 |
2009年 | 27篇 |
2008年 | 44篇 |
2007年 | 33篇 |
2006年 | 33篇 |
2005年 | 27篇 |
2004年 | 36篇 |
2003年 | 29篇 |
2002年 | 24篇 |
2001年 | 16篇 |
2000年 | 10篇 |
1999年 | 22篇 |
1998年 | 4篇 |
1997年 | 6篇 |
1996年 | 11篇 |
1995年 | 6篇 |
1994年 | 5篇 |
1993年 | 9篇 |
1992年 | 26篇 |
1991年 | 19篇 |
1990年 | 23篇 |
1989年 | 26篇 |
1988年 | 20篇 |
1987年 | 16篇 |
1986年 | 11篇 |
1985年 | 15篇 |
1984年 | 7篇 |
1983年 | 12篇 |
1982年 | 6篇 |
1981年 | 3篇 |
1980年 | 4篇 |
1979年 | 7篇 |
1978年 | 6篇 |
1977年 | 4篇 |
1976年 | 3篇 |
1975年 | 5篇 |
1962年 | 1篇 |
排序方式: 共有948条查询结果,搜索用时 15 毫秒
61.
62.
S S Metkar K N Naresh A A Redkar C S Soman S H Advani J J Nadkarni 《Leukemia & lymphoma》1999,33(5-6):521-530
Fas and Fas ligand expression were investigated in twenty two cases of classical Hodgkin's disease (HD) by immunohistochemistry. While Reed-Sternberg (RS) cells in 7/22 (32%) cases expressed Fas ligand, reactive lymphoid cells expressed Fas ligand in only 2 (9%) cases. In 20/22 (91%) cases, the RS cells expressed Fas. A higher proportion of RS cells in the nodular sclerosis subtype expressed Fas as compared to the mixed cellularity subtype. In 18/22 (82%) cases, Fas expression was also noted in the reactive lymphoid cells. In eight cases, the reactive lymphoid cells were also analyzed by flow cytometry and a majority of them were CD4+CD45RO+. Most of these activated T-cells expressed Fas but were negative for Fas Ligand. To investigate the co-expression of Fas and Fas Ligand in the RS cells, six cases were subjected to Fas and Fas ligand immunostaining on consecutive sections. The co-expression was documented in the RS cells in four of six cases. These six cases with expression of both Fas and Fas ligand were investigated for the incidence of apoptosis. There was no statistically significant relationship between expression of Fas on reactive cells, expression of FasL on RS cells and the proportion of apoptotic reactive cells. In all these cases apoptosis was not observed in the RS cells. Thus Fas - FasL interactions may not lead to apoptosis of the RS cells. 相似文献
63.
64.
65.
66.
Mittal Sakshi Naidu G. S. R. S. N. K. Jha Saket Rathi Manish Nada Ritambhra Minz Ranjana W Sharma Kusum Dhir Varun Jain Sanjay Sharma Aman 《Clinical rheumatology》2021,40(2):645-651
Clinical Rheumatology - To present single centre experience on the efficacy and safety of similar biologic of rituximab in patients with granulomatosis with polyangiitis (GPA). This was a... 相似文献
67.
68.
Lonidamine (LNA) is antitumor agent that lacks the characteristic properties of antiproliferative drugs and has narrow spectrum of antitumour effects. It is also a hyperthermia sensitizer. Hyperthermia affects on various cellular organelles, and the malignant cells are known to be more sensitive to hyperthermia. The present study examines the in vitro effects of LNA (0.01 and 0.02 mM) and hyperthermia (42 degrees C for 1 and 2 hrs) alone and in combination, on 11 human chronic myeloid leukemia cell samples. The inhibition in incorporation of 3H-thymidine was statistically significant (P less than 0.001) in human CML cells when exposed to the combination of LNA (0.01 and 0.02 mM) with hyperthermia (1 and 2 hrs) compared to the single treatment either at the same concentration of LNA at 37 degrees C or hyperthermia alone. Cytotoxicity was evaluated as the inhibition of the incorporation of 3H-thymidine in the cellular nucleic acid. The drug effects were estimated from the changes in rates of incorporation of precursor into DNA and compared with untreated control samples. Cancer cells were incubated in vitro in the presence of radioactive 3H-thymidine and drug. 相似文献
69.
S D Banavali K M Mohandas R Iyer R Gopal T K Saikia J N Kulkarni C S Krishnamurthy S C Soman S H Advani 《Indian journal of cancer》1991,28(2):70-74
We report two cases of primary extranodal lymphoma of the prostate, an unusual site for extranodal presentation. The clinical presentation and treatment is discussed. 相似文献
70.
Primary lymphoma of bone: a clinicopathologic study of 25 cases reported over 10 years 总被引:2,自引:0,他引:2
Twenty-five cases of primary lymphoma of bone (PLB) reported over a 10-year period were reviewed. The presenting symptom was related to involvement of a single bone with or without regional nodal disease. None showed dissemination of lymphoma in the subsequent six months. Patients affected were 7-65 years of age. An equal predilection for the axial and appendicular skeleton was noted. Histologically, the commonest subtype was diffuse histiocytic lymphoma (DHL, 17 cases), whereas four were poorly differentiated lymphocytic (PDL) type and another four were unclassifiable. Follow-up was available in 18 out of 25 patients for periods ranging from 7 months to 8 years. On clinicopathologic correlation we found that 75% of disease-free patients had a DHL whereas 60% of those alive with disease had a PDL. This study reiterates the view that PLB has a good prognosis and the DHL subtype is especially amenable to complete eradication. 相似文献